Galvin Gaustad & Stein’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $905K | Sell |
4,877
-1
| -0% | -$186 | 0.08% | 105 |
|
|
2025
Q1 | $1.02M | Buy |
4,878
+673
| +16% | +$141K | 0.09% | 97 |
|
|
2024
Q4 | $747K | Sell |
4,205
-28
| -0.7% | -$4.98K | 0.07% | 110 |
|
|
2024
Q3 | $836K | Buy |
4,233
+763
| +22% | +$151K | 0.07% | 103 |
|
|
2024
Q2 | $595K | Buy |
3,470
+16
| +0.5% | +$2.74K | 0.06% | 118 |
|
|
2024
Q1 | $629K | Sell |
3,454
-69
| -2% | -$12.6K | 0.06% | 108 |
|
|
2023
Q4 | $546K | Sell |
3,523
-419
| -11% | -$64.9K | 0.05% | 115 |
|
|
2023
Q3 | $588K | Sell |
3,942
-96,897
| -96% | -$14.4M | 0.06% | 107 |
|
|
2023
Q2 | $13.6M | Sell |
100,839
-9,619
| -9% | -$1.3M | 1.32% | 34 |
|
|
2023
Q1 | $17.6M | Sell |
110,458
-1,842
| -2% | -$294K | 1.73% | 24 |
|
|
2022
Q4 | $18.1M | Buy |
112,300
+6,352
| +6% | +$1.03M | 1.83% | 21 |
|
|
2022
Q3 | $14.2M | Sell |
105,948
-5,796
| -5% | -$778K | 1.51% | 29 |
|
|
2022
Q2 | $17.1M | Sell |
111,744
-17,273
| -13% | -$2.65M | 1.74% | 23 |
|
|
2022
Q1 | $20.9M | Sell |
129,017
-24,162
| -16% | -$3.92M | 1.89% | 16 |
|
|
2021
Q4 | $20.7M | Sell |
153,179
-10,115
| -6% | -$1.37M | 1.79% | 18 |
|
|
2021
Q3 | $17.6M | Buy |
+163,294
| New | +$17.6M | 1.7% | 19 |
|